首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
StockWatch: Investors Shrug as FDA Weighs First Gene-Edited Therapy
被引:0
|
作者
:
Philippidis A.
论文数:
0
引用数:
0
h-index:
0
Philippidis A.
机构
:
来源
:
Genetic Engineering and Biotechnology News
|
2023年
/ 5卷
/ 01期
关键词
:
Compendex;
D O I
:
10.1089/genedge.5.1.85
中图分类号
:
学科分类号
:
摘要
:
[No abstract available]
引用
收藏
页码:436 / 439
页数:3
相关论文
共 50 条
[31]
Spatiotemporal Immune Atlas of the First Clinical-Grade, Gene-Edited Pig-to-Human Kidney Xenotransplant
Cheung, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Alabama Birmingham, Birmingham, AL USA
Univ Alabama Birmingham, Birmingham, AL USA
Cheung, M.
论文数:
引用数:
h-index:
机构:
Asiimwe, R.
论文数:
引用数:
h-index:
机构:
George, J.
论文数:
引用数:
h-index:
机构:
Locke, J.
Porrett, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Alabama Birmingham, Birmingham, AL USA
Univ Alabama Birmingham, Birmingham, AL USA
Porrett, P.
AMERICAN JOURNAL OF TRANSPLANTATION,
2023,
23
(06)
: S560
-
S560
[32]
China Produces World's First Gene-Edited Dogs Using CRISPR/Cas9 System
Bulletin of the Chinese Academy of Sciences,
2015,
(04)
: 247
-
247
[33]
FDA approves first haemophilia B gene therapy
Asher Mullard
论文数:
0
引用数:
0
h-index:
0
Asher Mullard
Nature Reviews Drug Discovery,
2023,
22
: 7
-
7
[34]
FDA approves first haemophilia B gene therapy
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY,
2023,
22
(01)
: 7
-
7
[35]
First FDA-Approved Gene Therapy for Hemophilia
Larkin, Howard
论文数:
0
引用数:
0
h-index:
0
Larkin, Howard
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2023,
329
(01):
: 14
-
14
[36]
Single-Cell DNA Sequencing of Gene-Edited Cells Enables In-Depth Characterization of Cell and Gene Therapy Products
Wang, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Wang, S.
Gulati, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Gulati, S.
Yang, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Yang, Y.
Li, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Li, A.
Patel, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Patel, K.
Miltz, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Miltz, B.
Enzmann, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Enzmann, B.
Sahin, O.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Sahin, O.
Shroeder, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Miss Bio, San Francisco, CA USA
Miss Bio, San Francisco, CA USA
Shroeder, B.
HUMAN GENE THERAPY,
2024,
35
(3-4)
: A305
-
A305
[37]
FDA panel recommends approval of first gene therapy in US
Dyer, Owen
论文数:
0
引用数:
0
h-index:
0
Dyer, Owen
BMJ-BRITISH MEDICAL JOURNAL,
2017,
358
[38]
CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy
Philippidis, Alex
论文数:
0
引用数:
0
h-index:
0
机构:
Mary Ann Liebert Inc, New Rochelle, NY 10801 USA
Mary Ann Liebert Inc, New Rochelle, NY 10801 USA
Philippidis, Alex
HUMAN GENE THERAPY,
2024,
35
(1-2)
: 1
-
4
[39]
Gene-Edited Hematopoietic Stem Cells to Enable Next-Generation CAR-T Cell Therapy for the Treatment of AML
Etchin, Julia
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Etchin, Julia
Keschner, Yonina
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Keschner, Yonina
Silva, Mariana
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Canc Immunotherapy, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Silva, Mariana
Hoyt, Hillary
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Canc Immunotherapy, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Hoyt, Hillary
Ung, Matthew
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Quantitat Biol, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Ung, Matthew
Manalo, Nathan
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Preclin & Translat Biol, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Manalo, Nathan
Xavier-Ferrucio, Juliana
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Preclin & Translat Biol, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Xavier-Ferrucio, Juliana
Halfond, Amanda
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Halfond, Amanda
DiFazio, Julia
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
DiFazio, Julia
Lin, Michelle
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Preclin & Translat Biol, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Lin, Michelle
Scherer, Julian
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Canc Immunotherapy, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Scherer, Julian
Lydeard, John R.
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Lydeard, John R.
Chakraborty, Tirtha
论文数:
0
引用数:
0
h-index:
0
机构:
Vor Biopharma, Cambridge, MA USA
Vor Biopharma, Discovery & Mol Engn, Cambridge, MA USA
Chakraborty, Tirtha
MOLECULAR THERAPY,
2024,
32
(04)
: 828
-
828
[40]
A message from Mr. David Bennett Jr., the son of the first patient to receive a gene-edited pig heart transplant
Bennett, David
论文数:
0
引用数:
0
h-index:
0
Bennett, David
XENOTRANSPLANTATION,
2023,
30
(06)
←
1
2
3
4
5
→